From the Villanova Health Summit's Speaker Event, host Dr. Matt Birnholz speaks with guest Dr. Robert McNally, President, and CEO of GeoVax, Inc. They discuss the challenges that biotech companies face when bringing vaccines through clinical trials, and the long-term project being conducted by his colleagues to deliver an HIV vaccine to market.
ReachMD
Be part of the knowledge.™The HIV Vaccine's Path Through Clinical Trials: A Biotech CEO's Perspective
close
Choose a format
Media formats available:
Programs 3/30/20
Facebook Comments